ASCO-slider Eye on ASCO Day 4 - Moonshots, Money and Mobile apps You don't often get searched by the US secret service at a medical meeting.
Partner Content Partner Content The HNSCC immunotherapy race is on - and it's going to be cl... While improper to compare life saving treatments to buses - the metaphor when it comes to head and neck squamous cell carcinoma (HNSCC) is clear.
R&D T-cell specialist Immunocore raises $320m in private finance Immunocore, a UK-based biotech specialising in T-cell receptor drugs has raised $320 million (£205 million), making it Europe's largest private life sciences financing.
Cancer Lilly and Immunocore collaborate on novel cancer therapies Eli Lilly and Immunocore have agreed to collaborate on R&D into novel T-cell-based cancer therapies.
News Biden ramps up Medicare coverage of obesity drugs Outgoing US President Joe Biden has proposed a dramatic expansion of Medicare coverage of obesity drugs, but will the plan see the light of day?
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends
